Cargando…

Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury

Podocyte injury is an independent risk factor for the progression of renal diseases. Semaphorin3A (SEMA3A), expressed in podocytes and tubular cells in the mammalian adult kidneys, has been reported to regulate diverse biological functions and be associated with renal diseases. Here, we investigated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sang, Yizhen, Tsuji, Kenji, Inoue-Torii, Akiko, Fukushima, Kazuhiko, Kitamura, Shinji, Wada, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312798/ https://www.ncbi.nlm.nih.gov/pubmed/32521824 http://dx.doi.org/10.3390/ijms21114099

Ejemplares similares

Role of Semaphorin 3A in Kidney Development and Diseases
por: Sang, Yizhen, et al.
Publicado: (2023)

Sodium Glucose Co-Transporter 2 Inhibitor Ameliorates Autophagic Flux Impairment on Renal Proximal Tubular Cells in Obesity Mice
por: Fukushima, Kazuhiko, et al.
Publicado: (2020)

The level of urinary semaphorin3A is associated with disease activity in patients with minimal change nephrotic syndrome
por: Inoue-Torii, Akiko, et al.
Publicado: (2017)

Deep Learning Could Diagnose Diabetic Nephropathy with Renal Pathological Immunofluorescent Images
por: Kitamura, Shinji, et al.
Publicado: (2020)

Sodium–Glucose Cotransporter 2 Inhibitors Work as a “Regulator” of Autophagic Activity in Overnutrition Diseases
por: Fukushima, Kazuhiko, et al.
Publicado: (2021)

MicroRNAs as Biomarkers and Therapeutic Targets for Acute Kidney Injury
por: Tsuji, Kenji, et al.
Publicado: (2023)

Wedelolactone-Loaded Micelles Ameliorate Doxorubicin-Induced Oxidative Injury in Podocytes by Improving Permeability and Bioavailability
por: Feng, Liang, et al.
Publicado: (2019)

The association between hypothyroidism and proteinuria in patients with chronic kidney disease: a cross-sectional study
por: Matsuoka-Uchiyama, Natsumi, et al.
Publicado: (2022)

Kidney Veno-Muscular Characteristics and Kidney Disease Progression: A Native Kidney-Biopsy Study
por: Tsuji, Kenji, et al.
Publicado: (2023)

Secretomes from Mesenchymal Stem Cells against Acute Kidney Injury: Possible Heterogeneity
por: Tsuji, Kenji, et al.
Publicado: (2018)

A novel podocyte gene, semaphorin 3G, protects glomerular podocyte from lipopolysaccharide-induced inflammation
por: Ishibashi, Ryoichi, et al.
Publicado: (2016)

Puromycin aminonucleoside‐induced podocyte injury is ameliorated by the Smad3 inhibitor SIS3
por: Jiang, Lina, et al.
Publicado: (2020)

Paclitaxel Ameliorates Palmitate-Induced Injury in Mouse Podocytes
por: Son, Seung Seob, et al.
Publicado: (2020)

Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Renal Diseases
por: Tsuji, Kenji, et al.
Publicado: (2020)

MicroRNAs as Biomarkers for Nephrotic Syndrome
por: Tsuji, Kenji, et al.
Publicado: (2020)

Potential Strategies for Kidney Regeneration With Stem Cells: An Overview
por: Tsuji, Kenji, et al.
Publicado: (2022)

Twist1 in podocytes ameliorates podocyte injury and proteinuria by limiting CCL2-dependent macrophage infiltration
por: Ren, Jiafa, et al.
Publicado: (2021)

Podocyte specific deletion of PKM2 ameliorates LPS-induced podocyte injury through beta-catenin
por: Alquraishi, Mohammed, et al.
Publicado: (2022)

Tubulointerstitial Nephritis Cases With IgM-Positive Plasma Cells
por: Matsuoka-Uchiyama, Natsumi, et al.
Publicado: (2020)

Pembrolizumab-induced hypothyroidism caused reversible increased serum creatinine levels: a case report
por: Matsuoka, Natsumi, et al.
Publicado: (2020)

Association between Urinary Creatinine Excretion and Hypothyroidism in Patients with Chronic Kidney Disease
por: Matsuoka-Uchiyama, Natsumi, et al.
Publicado: (2023)

Astragaloside II Ameliorated Podocyte Injury and Mitochondrial Dysfunction in Streptozotocin-Induced Diabetic Rats
por: Su, Jun, et al.
Publicado: (2021)

Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway
por: Trohatou, Ourania, et al.
Publicado: (2017)

Catalpol Ameliorates Podocyte Injury by Stabilizing Cytoskeleton and Enhancing Autophagy in Diabetic Nephropathy
por: Chen, Yan, et al.
Publicado: (2019)

GAP-43 ameliorates Podocyte injury by decreasing nuclear NFATc1 expression
por: Lian, Zhiwen, et al.
Publicado: (2021)

The semaphorins
por: Yazdani, Umar, et al.
Publicado: (2006)

Polydatin impairs mitochondria fitness and ameliorates podocyte injury by suppressing Drp1 expression
por: Ni, Zheng, et al.
Publicado: (2017)

Klotho Ameliorates Podocyte Injury through Targeting TRPC6 Channel in Diabetic Nephropathy
por: Yao, Xingmei, et al.
Publicado: (2022)

Selective Inhibition of Histone Deacetylase Class IIa With MC1568 Ameliorates Podocyte Injury
por: He, Xu, et al.
Publicado: (2022)

Vitamin D Ameliorates Podocyte Injury by Enhancing Autophagy Activity in Diabetic Kidney Disease
por: Zhang, Xiaoyi, et al.
Publicado: (2023)

Co-occurrence of Three Systemic Diseases: ANCA-associated Vasculitis, Sjögren's syndrome and Sarcoidosis
por: Tsuji, Kenji, et al.
Publicado: (2022)

Genipin Inhibits Mitochondrial Uncoupling Protein 2 Expression and Ameliorates Podocyte Injury in Diabetic Mice
por: Qiu, Wenjing, et al.
Publicado: (2012)

Silica-associated systemic lupus erythematosus with lupus nephritis and lupus pneumonitis: A case report and a systematic review of the literature
por: Fukushima, Kazuhiko, et al.
Publicado: (2022)

Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases
por: Kubo, Ayano, et al.
Publicado: (2020)

Podocyte-specific Rac1 deficiency ameliorates podocyte damage and proteinuria in STZ-induced diabetic nephropathy in mice
por: Lv, Zhimei, et al.
Publicado: (2018)

Mosaicism of Podocyte Involvement Is Related to Podocyte Injury in Females with Fabry Disease
por: Mauer, Michael, et al.
Publicado: (2014)

Podocyte Injury in Lupus Nephritis
por: Sakhi, Hamza, et al.
Publicado: (2019)

Role of Podocyte Injury in Glomerulosclerosis
por: Lu, Chen-Chen, et al.
Publicado: (2019)

Semaphorins—not just for axons
por: LeBrasseur, Nicole
Publicado: (2002)

Peptide vaccine for semaphorin3E ameliorates systemic glucose intolerance in mice with dietary obesity
por: Yoshida, Yohko, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ei1ahkml2rk40au9cj62gpvffa